LATS1 and neoplasm: We previously reported that tumor cells deficient in large tumor suppressor kinase (LATS)1/2 (part of the Hippo pathway) released immunostimulatory EVs carrying tumor-specific antigens and RNA (Moroishi et al., 2016).